| Advances in skin regeneration using tissue engineering K Vig, A Chaudhari, S Tripathi, S Dixit, R Sahu, S Pillai, VA Dennis, ... International journal of molecular sciences 18 (4), 789, 2017 | 703 | 2017 |
| AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature CY Shweta Tripathi, Melissa Davis, Raymond Hughley Plos One 13 (6), e0196909, 2018 | 61 | 2018 |
| Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine HS Sabnis, HL Bradley, S Tripathi, WM Yu, W Tse, CK Qu, KD Bunting Leukemia research 50, 132-140, 2016 | 30 | 2016 |
| Quadruple negative breast cancers (QNBC) demonstrate subtype consistency among primary and recurrent or metastatic breast cancer A Angajala, E Mothershed, MB Davis, S Tripathi, Q He, D Bedi, ... Translational Oncology 12 (3), 493-501, 2019 | 29 | 2019 |
| Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system CM Lee, S Tripathi, ET Morgan Free Radical Biology and Medicine 108, 478-486, 2017 | 21 | 2017 |
| Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2 H Sun, C Lee, S Tripathi, KB Kim, ET Morgan Biochemical Journal 445 (3), 377-382, 2012 | 13 | 2012 |
| Abstract B052: Identification of differentially expressed micro-RNAs in African American women with Quadruple Negative Breast Cancer A Angajala, RH Anusha Angajala, S Tripathi, WD Columb, M Tan, C Yates American Association for Cancer Research 29 (6), 2020 | 2 | 2020 |
| Identification of differentially expressed microRNAs in African American women with quadruple-negative breast cancer A Angajala, R Hughley, W DeanColomb, S Tripathi, M Tan, C Yates Cancer Research 78 (13_Supplement), 4769-4769, 2018 | 2 | 2018 |
| Cyclooxygenase-2-dependent and-independent effects of etoricoxib in human cervical cancer cell lines S Tripathi, B Dwarkanath, S Chandna, D Saluja, M Chopra Cancer Research 70 (8_Supplement), 5671-5671, 2010 | 1 | 2010 |
| Targeted therapies for QNBC patients based on immune and basal signature correlations to race. RW Hughley, WD Colomb, S Tripathi, C Yates CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 55-56, 2018 | | 2018 |
| Abstract P3-05-11: Immune and basal signature correlation to targeted therapies and race in QNBC patients RW Hughley, WD Colomb, T Shweta, C Yates Cancer Research 78 (4_Supplement), P3-05-11-P3-05-11, 2018 | | 2018 |
| “Hydrogel Scaffold Designing for Tissue Engineering” B Wilson, S Tripathi, K Vig Annual Biomedical Research Conference For Minority Students (ABRCMS …, 2017 | | 2017 |
| Correlation of QNBC immune and basal signature to targeted therapies and race. RW Hughley, WM Dean-Colomb, S Tripathi, M Davis, CC Yates Journal of Clinical Oncology 35 (15_suppl), e14537-e14537, 2017 | | 2017 |
| Quadruple Negative Breast Cancers in African American women have an enriched Basal and Immune signature. S Tripathi, MB Davis, R Hughley, Q He, S Bae, WE Grizzle, B Karanam, ... The Journal of Immunology 198 (1_Supplement), 76.5-76.5, 2017 | | 2017 |
| miRNA Expression Analysis in Hep2 cells after Gold Nanorod Application KV Aundrya Montgomery, Swapnil Bawage, Shweta Tripathi, Atul Chaudhuri ... Biotech, Biomaterials and Biomedical: Tech Connect Briefs 2017, 2017 | | 2017 |
| Targeting subcellular localization of Kaiso to limit dissemination through MAPK signaling S Tripathi, B Karanam, B Ma, A Wells, C Yates Cancer Research 76 (14_Supplement), 1680-1680, 2016 | | 2016 |
| Quadruple negative tumors to demonstrate unique pairwise gene associations linked to recurrent and metastatic breast cancer. CC Yates, E Mothershed, M Davis, S Tripathi, WM Dean-Colomb Journal of Clinical Oncology 34 (15_suppl), e12565-e12565, 2016 | | 2016 |
| The Development of a Genomic Health Disparity Database and Analytic Tool RW Hughley, S Tripathi, M Davis, C Yates The FASEB Journal 30, lb445-lb445, 2016 | | 2016 |
| Synergistic Cytotoxicity in Acute Myeloid Leukemia By Combined Treatment with Metformin and 6-Benzylthioinosine HS Sabnis, S Tripathi, HL Bradley, WM Yu, W Tse, CK Qu, KD Bunting Blood 124 (21), 3754, 2014 | | 2014 |
| Abstract A37: Mechanistic study involving antiproliferative effect of Etoricoxib, a highly selective COX‐2 inhibitor on human cancer cell lines S Tripathi, S Chandna, BS Dwarkanath, D Saluja, M Chopra Cancer Research 69 (23_Supplement), A37-A37, 2009 | | 2009 |
